Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

OBJECTIVES: Many patients with rheumatoid arthritis (RA) require treatment with tumour necrosis factor inhibitor (TNFi) to reach remission. It is debated whether tapering of TNFi to discontinuation should be considered in sustained remission. The aim of ARCTIC REWIND TNFi was to assess the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lillegraven, Siri, Paulshus Sundlisæter, Nina, Aga, Anna-Birgitte, Sexton, Joseph, Olsen, Inge Christoffer, Lexberg, Åse Stavland, Madland, Tor Magne, Fremstad, Hallvard, Høili, Christian A., Bakland, Gunnstein, Spada, Cristina, Haukeland, Hilde, Hansen, Inger Myrnes, Moholt, Ellen, Uhlig, Till, Solomon, Daniel H, van der Heijde, Désirée, Kvien, Tore K, Haavardsholm, Espen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579188/
https://www.ncbi.nlm.nih.gov/pubmed/37607809
http://dx.doi.org/10.1136/ard-2023-224476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579188/
https://www.ncbi.nlm.nih.gov/pubmed/37607809
http://dx.doi.org/10.1136/ard-2023-224476

Ejemplares similares